Brief: Ocugen Announces European Medicines Agency Grants Orphan Medicinal Product Designation For Modifier Gene Therapy Candidate Ocu410st
20/11/2024 12:42
Nov 20 (Reuters) - Ocugen Inc OCGN.O :
* OCUGEN ANNOUNCES EUROPEAN MEDICINES AGENCY GRANTS ORPHAN
MEDICINAL PRODUCT DESIGNATION FOR MODIFIER GENE THERAPY
CANDIDATE OCU410ST FOR TREATMENT OF ABCA4-ASSOCIATED
RETINOPATHIES INCLUDING STARGARDT DISEASE
* OCUGEN INC - TO PURSUE ACCELERATED MARKETING AUTHORIZATION
APPLICATION FOR OCU410ST
Source text: ID:nGNX6Zfsqg
Further company coverage: OCGN.O
((Reuters.Briefs@thomsonreuters.com;))